Equities

Dalrada Financial Corp

DFCO:QBB

Dalrada Financial Corp

Actions
  • Price (USD)0.163
  • Today's Change-0.007 / -4.12%
  • Shares traded25.24k
  • 1 Year change+8.88%
  • Beta1.3248
Data delayed at least 15 minutes, as of Jul 26 2024 20:21 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Dalrada Financial Corporation is a multi-national holding company that develops, manufactures, and sells a robust suite of products and services in the clean energy and health care sectors. The Company has five business divisions: Genefic, Dalrada Climate Technology, Dalrada Precision Manufacturing, Dalrada Technologies and Dalrada Corporate. Genefic delivers advanced health care solutions with products, services and systems. Genefic’s pharmacy solution, Genefic Specialty Pharmacy, provides end-to-end prescription services as well as patient advocacy and support. Dalrada Climate Technology offers cutting-edge heat pump technology for industrial and residential applications. Dalrada Precision Manufacturing creates total manufacturing solutions. Dalrada Technologies creates digital products with computer information technology and software engineering services for a variety of technical industries and clients in both business-to-business (B2B) and business-to-customer (B2C) environments.

  • Revenue in USD (TTM)32.16m
  • Net income in USD-21.34m
  • Incorporated1983
  • Employees0.00
  • Location
    Dalrada Financial Corp600 LA TERRAZA BOULEVARDESCONDIDO 92025United StatesUSA
  • Phone+1 (858) 283-1253
  • Fax+1 (858) 277-3448
  • Websitehttps://dalrada.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
LiveCare Inc0.00-2.34m10.18m----4.32-----0.1411-0.14110.000.04630.00-------424.83---550.62-------------8.180.1888-------344.86------
PetVivo Holdings Inc968.71k-10.96m12.94m20.00--16.16--13.36-0.8091-0.80910.06940.04020.34880.602818.3948,435.50-394.49-230.77-815.08-467.9976.3466.21-1,130.92-1,501.440.4613-1,644.170.1993--5.62---25.67--23.91--
Nexalin Technology Inc158.86k-4.94m13.13m6.00--3.96--82.63-0.6676-0.66760.02150.31290.03630.177844.0126,476.67-112.76---139.94--82.54---3,110.58--4.75--0.00---91.62---173.80------
Vapotherm Inc70.07m-54.94m13.24m182.00------0.1889-8.62-8.6211.00-11.020.81221.467.53385,011.00-63.68-49.73-587.27-62.5445.2843.56-78.40-78.990.1259-1.272.59--2.8010.1448.62---10.38--
QT Imaging Holdings Inc0.00-4.02m13.72m----0.6312-----0.3999-0.39990.001.010.00-------12.32---16.60--------------0.3042-------45.07------
STRATA Skin Sciences Inc32.55m-11.36m13.93m99.00--1.24--0.4281-3.25-3.259.312.690.733.678.60328,737.40-25.49-11.48-35.77-16.5552.7161.28-34.91-17.700.8376-3.900.6151---7.752.24-95.17--23.29--
REMSleep Holdings Inc175.95k-1.80m14.46m6.00--21.36--82.17-0.0012-0.00120.00010.00050.08481.6911.20---86.95-152.40-108.40-317.98-411.78---1,025.38-2,317.521.63-18.540.0673---36.48--12.13--28.26--
Dalrada Financial Corporation32.16m-21.34m15.82m0.00--1.79--0.492-0.2388-0.23880.35730.0911.098.863.37---75.10-80.63-239.06--30.1139.23-68.78-63.941.24-21.540.3452--54.35---43.94------
Biotricity Inc12.06m-14.93m16.11m55.00------1.34-1.66-1.661.34-3.151.941.768.96219,333.60-226.36-269.25----69.2758.93-116.84-258.940.1142-0.711----25.1597.8223.57------
SANUWAVE Health Inc22.41m-17.26m17.72m31.00------0.7908-0.0267-0.02670.0238-0.04171.103.607.50722,838.70-84.54-136.54----71.6369.13-77.00-189.600.11930.0192----21.8461.61-150.72------
Bionoid Pharma Inc0.001.35m18.36m13.000.2998--13.57--1.131.130.00-0.1744-----------506.64--------------327.24---------31.55--26.01--
Orgenesis Inc529.00k-45.66m18.59m146.00------35.15-1.53-1.530.0174-0.80720.010149.690.0493,623.29-98.12---338.48---660.87---9,744.05--0.0662-12.23-----98.53-50.94-271.82---17.71--
Scientific Industries Inc10.79m-8.77m19.80m63.00--1.57--1.84-1.13-1.131.341.200.67621.199.31171,263.50-54.96---63.27--44.53---81.28--3.19--0.00--------------
Inspira Technologies Oxy BHN Ltd0.00-11.29m20.01m37.00--2.97-----0.9549-0.95490.000.36660.00----0.00-88.60-114.98-108.36-159.56------------0.00------24.64------
Golden Valley Development Inc0.00-92.53k20.52m0.00---------11.17-11.170.00-0.02110.00-------7,710.83-------------3,073.27---3.96--------45.48------
Neuraxis Inc2.30m-14.39m21.21m19.00------9.21-3.71-3.710.4945-0.48291.825.8110.14121,135.80-1,154.78------87.72---633.21--0.1016-13.46-----8.37---163.78------
Data as of Jul 26 2024. Currency figures normalised to Dalrada Financial Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.